KMTS vs STVN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KMTS · Kestra Medical Technologies$28.80 ▲ 0.95%
STVN · Stevanato Group$13.57 ▲ 2.73%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KMTS +9.0%
- STVN -43.8%
Head to head
| Metric | KMTS | STVN |
|---|---|---|
| Price | $28.80 | $13.57 |
| Change today | ▲ 0.95% | ▲ 2.73% |
| Market cap | $1.72B | $3.71B |
| Return, 3 months | +1.6% | -34.1% |
| Return, year to date | +8.6% | -32.3% |
| Return, 1 year | +9.8% | -43.5% |
| P/E (TTM) | -11.4 | 23.7 |
| P/B | 7.7 | 2.1 |
| P/E percentile vs own 5y | 16th | 43rd |
| Dividend yield | – | 0.45% |
| Revenue growth (YoY, latest qtr) | +59.9% | +7.8% |
| Net profit growth (YoY) | -70.7% | -22.7% |
| Gross margin | 53.9% | 29.2% |
| Operating margin | -134.5% | 17.4% |
| Net margin | -140.4% | 11.0% |
| Return on equity | -73.7% | 9.1% |
| Analyst target vs. price | +4.2% | +71.3% |
| Analyst buy share | 100% | 67% |
| RSI (14) | 52 | 23 |
| 30-day volatility | 65.8% | 102.2% |
| Max drawdown, 1 year | -36.2% | -49.0% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- STVN is the largest of the group by market value.
- KMTS has returned the most over the past year.
- KMTS carries the lowest trailing P/E.
- KMTS is growing revenue fastest.
- STVN keeps the most profit per dollar of sales.
- KMTS has been the calmest stock over the last 30 days.